- About us
- Site map
- Contact Us
- Contact Us
The CBIC vide Notification No. 27/2021 – Customs dated 20 April 2021 has exempted Remdesivir and active pharmaceutical ingredients from the levy of Customs Duty, until 31 October 2021. Further, a conditional customs duty exemption has been granted for the ingredient Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir, till 31 October 2021.
Given the current situation of the COVID-19 pandemic, and the scarcity of vaccines, it was utmost important to provide such exemption upon import of vaccine ingredients. This would definitely help increase the production and supply of the anti-COVID-19 drugs, especially in view of the sudden surge in the demand of Remdesivir in the last few days.
The information provided in this update is intended for informational purposes only and does not constitute legal opinion or advice. Readers are requested to seek formal legal advice prior to acting upon any of the information provided herein. This update is not intended to address the circumstances of any particular individual or corporate body. There can be no assurance that the judicial/ quasi judicial authorities may not take a position contrary to the views mentioned hereinrra quis.
Sign up for the Newsletter